# Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)

> **NCT01414868** · NA · COMPLETED · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 32 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** leukotriene receptor antagonist (montelukast)

## Key facts

- **NCT ID:** NCT01414868
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414868, "Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01414868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*